Proliferating cell nuclear antigen

Source: Wikipedia, the free encyclopedia.
PCNA
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_182649
NM_002592

NM_011045

RefSeq (protein)

NP_002583
NP_872590

NP_035175

Location (UCSC)Chr 20: 5.11 – 5.13 MbChr 2: 132.09 – 132.1 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Cryo-EM structure of the DNA-bound PolD–PCNA processive complex

Proliferating cell nuclear antigen (PCNA) is a

eukaryotic cells and is essential for replication. PCNA is a homotrimer and achieves its processivity by encircling the DNA, where it acts as a scaffold to recruit proteins involved in DNA replication, DNA repair, chromatin remodeling and epigenetics.[5]

Many proteins interact with PCNA via the two known PCNA-interacting motifs PCNA-interacting peptide (PIP) box[6] and AlkB homologue 2 PCNA interacting motif (APIM).[7] Proteins binding to PCNA via the PIP-box are mainly involved in DNA replication whereas proteins binding to PCNA via APIM are mainly important in the context of genotoxic stress.[8]

Function

The protein encoded by this gene is found in the nucleus and is a cofactor of DNA polymerase delta. The encoded protein acts as a homotrimer and helps increase the processivity of leading strand synthesis during DNA replication. In response to DNA damage, this protein is ubiquitinated and is involved in the RAD6-dependent DNA repair pathway. Two transcript variants encoding the same protein have been found for this gene. Pseudogenes of this gene have been described on chromosome 4 and on the X chromosome.[9]

PCNA is also found in archaea, as a processivity factor of polD, the single multi-functional DNA polymerase in this domain of life.[10]

Expression in the nucleus during DNA synthesis

PCNA was originally identified as an

AAA+ class of ATPases. Expression of PCNA is under the control of E2F transcription factor-containing complexes.[15]
[16]

Role in DNA repair

Since DNA polymerase epsilon is involved in resynthesis of excised damaged DNA strands during DNA repair, PCNA is important for both DNA synthesis and DNA repair.[17][18]

PCNA is also involved in the DNA damage tolerance pathway known as post-replication repair (PRR).[19] In PRR, there are two sub-pathways: (1) a

translesion synthesis
pathway, which is carried out by specialised DNA polymerases that are able to incorporate damaged DNA bases into their active sites (unlike the normal replicative polymerase, which stall), and hence bypass the damage, and (2) a proposed "template switch" pathway that is thought to involve damage bypass by recruitment of the homologous recombination machinery. PCNA is pivotal to the activation of these pathways and the choice as to which pathway is utilised by the cell. PCNA becomes post-translationally modified by
Rad51
nucleoprotein filaments fundamental for initiation of homologous recombination.

PCNA-binding proteins

PCNA interacts with many proteins.[22]

Interactions

PCNA has been shown to

interact
with:

Proteins interacting with PCNA via APIM include human AlkB homologue 2, TFIIS-L, TFII-I, Rad51B,[7] XPA,[88] ZRANB3,[89] and FBH1.[90]

Uses

neoplasms, e.g. astrocytoma. They can be of diagnostic and prognostic value. Imaging of the nuclear distribution of PCNA (via antibody labeling) can be used to distinguish between early, mid and late S phase of the cell cycle.[91] However, an important limitation of antibodies
is that cells need to be fixed leading to potential artifacts.

On the other hand, the study of the dynamics of replication and repair in living cells can be done by introducing translational fusions of PCNA. To eliminate the need for transfection and bypass the problem of difficult to transfect and/or short lived cells, cell permeable replication and/or repair markers can be used. These peptides offer the distinct advantage that they can be used in situ in living tissue and even distinguish cells undergoing replication from cells undergoing repair.[92]

caPCNA, a post-translationally modified isoform of PCNA common in cancer cells, is a potential therapeutic target in cancer therapy.[93][94] In 2023 City of Hope National Medical Center published preclinical research on a targeted chemotherapy using AOH1996 that appears to suppress tumor growth without causing discernable side effects.[95]

See also

  • Ki-67 – cellular marker for proliferation
  • Transcription

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000132646Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000027342Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. S2CID 3547069
    .
  6. .
  7. ^ .
  8. .
  9. ^ "Entrez Gene: PCNA proliferating cell nuclear antigen".
  10. PMID 32221299
    .
  11. .
  12. .
  13. .
  14. .
  15. .
  16. .
  17. .
  18. .
  19. .
  20. ^ .
  21. .
  22. .
  23. .
  24. ^ .
  25. .
  26. .
  27. .
  28. .
  29. .
  30. ^ .
  31. .
  32. .
  33. ^ .
  34. .
  35. .
  36. .
  37. .
  38. .
  39. .
  40. .
  41. ^ .
  42. .
  43. .
  44. .
  45. ^ .
  46. .
  47. .
  48. .
  49. .
  50. .
  51. .
  52. .
  53. .
  54. .
  55. .
  56. .
  57. ^ .
  58. .
  59. .
  60. ^ .
  61. ^ .
  62. .
  63. ^ .
  64. .
  65. .
  66. .
  67. .
  68. .
  69. .
  70. .
  71. .
  72. .
  73. .
  74. .
  75. .
  76. ^ .
  77. .
  78. ^ .
  79. .
  80. .
  81. .
  82. .
  83. .
  84. .
  85. .
  86. .
  87. .
  88. .
  89. .
  90. .
  91. .
  92. .
  93. .
  94. .
  95. .

Further reading

External links